Verify any claim · lenz.io
“Spire Healthcare Group agreed to a 250p-per-share takeover offer from an investor consortium led by Toscafund Asset Management that values the company at approximately £1.03 billion.”
The conclusion
The reported deal terms are firmly supported by official materials and multiple current news reports. Spire agreed to a 250p-per-share cash offer from a consortium involving Toscafund, Three Hills and Ares, valuing its share capital at approximately £1.03 billion. The agreement is confirmed, although takeover completion remains subject to the deal process.
Caveats
- An agreed or recommended takeover offer is not the same as a completed acquisition.
- The bidder is Tulip UK Bidco, backed by Toscafund, Three Hills and Ares funds.
- The approximately £1.03 billion figure refers to Spire's equity or share-capital valuation, not necessarily enterprise value.
Fact-check inside the tools you already use
Connect Lenz to ChatGPT, Claude, or WhatsApp and check a claim mid-conversation.
Or create a free account to bookmark this verification and run your own checks.
Sources
Ranked by source quality and relevance
The takeover offer comes from a newly-formed company, named Tulip UK, comprised of funds managed or advised by Toscafund Asset Management, THCP Advisory and Ares Management. … Under the terms of the deal, Spire shareholders have been offered 250p per share. … The deal values Spire’s entire share capital at about £1.03 billion on a fully diluted basis.
OFFEREE: Spire Healthcare Group plc · LEI: 213800IBJPW3SE2RA350 Offer period commenced: 19:36 18-Sep-2025 1p ordinary · ISIN: GB00BNLPYF73 · NSI: 402,759,599 OFFEROR: Funds advised by Toscafund Asset Management LLP · LEI: Offeror identified: 07:00 14-May-2026 Rule 2.6 deadline: 17:00 21-Aug-2026 Disclosure of dealings and positions in this offeror is not required
Tulip UK Bidco Ltd, a newly formed company owned by funds managed or advised by Toscafund Asset Management LLP, THCP Advisory Ltd and Ares Management Ltd, will pay 250 pence in cash for each Spire share. … The offer values Spire's equity at GBP1.03 billion.
Spire Healthcare, which owns the Claremont hospital in Sheffield and St Anthony’s hospital in south London, has agreed to a 250p a share offer by an investor group led by Toscafund Asset Management, which valu
Under the terms of the agreement, shareholders will receive 250p per share. This proposal reflects a premium of approximately 66 per cent compared to Spire’s closing price on 13 May, the final trading day before negotiations were made public. Overall, the deal values the group's entire share capital at roughly £1.03 billion on a fully diluted basis.
Spire Healthcare Group said on Saturday it had agreed to be taken over by consortium comprising funds managed by Toscafund, Three Hills and Ares, valuing its share capital at about £1,026 million ($1.39 billion).
Spire’s board have agreed a takeover by Tulip UK Bidco, a new company comprising British investment firm Toscafund, UK private equity firm THCP Advisory and California-based investment manager Ares. … The 250p-per-share deal values the takeover at £1.03bn and constitutes a 66 per cent premium to Spire’s share price at the start of May, when Toscafund made its first approach.
Spire Healthcare Group said on Saturday it had agreed to be taken over by consortium comprising funds managed by Toscafund, Three Hills and Ares, valuing its share capital at about £1,026 million ($1.39 billion). … “Having conducted a comprehensive strategic review, the board is satisfied that the acquisition represents the best available outcome for Spire shareholders,” she said, adding that the 250-pence-a-share offer was the highest proposal the company had received during a strategic review.
Spire Healthcare has agreed to a £1.026 billion takeover at 250 pence per share by a consortium led by Toscafund, Three Hills and Ares, representing a 66% premium to its pre-offer market cap.
Spire Healthcare Group said on Saturday it had agreed to be taken over by consortium comprising funds managed by Toscafund, Three Hills and Ares, valuing its share capital at about £1,026 million ($1.39 billion).
The asset manager tabled its 250 pence-per-share proposal on May 14, a 66% premium to Spire's previous close, valuing the company at about £1 billion ($1.32 billion)
The potential cash offer remains at 250 pence per Spire Healthcare share, a figure last revised on 14 May 2026. … The announcement clearly states there is no certainty that a firm offer will be made, even if all pre-conditions are met or waived.
The UK private hospital group has agreed to be acquired by a consortium made up of funds managed by Toscafund, Three Hills and Ares, in a transaction that puts a value of roughly £1.03 billion ($1.39 billion) on Spire Healthcare’s share capital. … The terms of the deal will see Spire Healthcare shareholders paid 250 pence in cash for each share held.
You are attempting to enter the area of this website that is designated for the publication of documents and information in connection with the proposed offer (the Offer) by Ramsay Healthcare Limited (Ramsay) for Spire Healthcare Group plc (the Company) to be implemented by means of a scheme of arrangement.
OFFEREE: Spire Healthcare Group plc · LEI: 213800IBJPW3SE2RA350 Offer period commenced: 19:36 18-Sep-2025 1p ordinary · ISIN: GB00BNLPYF73 · NSI: 402,759,599 No named offeror
Ramsay Increased And Final Recommended Offer 05 July 2021
Continue your research
Verify a related claim next.
Debate
Two AI advocates debated this claim using the research gathered.
Argument for
Multiple independent outlets confirm Spire Healthcare Group agreed to a 250p-per-share cash takeover by Tulip UK Bidco, a consortium of funds managed or advised by Toscafund Asset Management with THCP/Three Hills and Ares, valuing the equity at about £1.03 billion (Sources 1 standard.co.uk, 3 lse.co.uk, 5 independent.co.uk, 7 cityam.com). The Guardian and further LSE/SRN reports likewise state the board accepted the Toscafund-led 250p offer at that valuation, establishing clear consensus that the claim is accurate (Sources 4 theguardian.com, 6 lse.co.uk, 8 srnnews.com).
The Proponent's appeal to repeated media reports is an argumentum ad populum rather than evidence that the asserted transaction was legally settled, particularly because the official Takeover Panel record still identifies only funds advised by Toscafund as offeror and records the Rule 2.6 process (Source 2, The Takeover Panel). Moreover, the cited reports expressly identify Tulip UK Bidco as a vehicle owned by funds associated with Toscafund, THCP Advisory and Ares Management, so describing the acquirer simply as an investor consortium “led by Toscafund” elides the material bidder-identity distinction that renders the atomic claim imprecise (Sources 1, The Standard; 3, LSE).
Argument against
The claim overstates a proposal as a settled takeover: the Takeover Panel's official disclosure table identifies only “Funds advised by Toscafund” as offeror and records a Rule 2.6 deadline, while the most recent pre-announcement evidence explicitly said there was “no certainty” that a firm offer would be made (Source 2, The Takeover Panel; Source 12, Kalkine Media). It also inaccurately compresses the bidder's identity into a Toscafund-led consortium, whereas the reported bidder is Tulip UK Bidco, owned by funds managed or advised by Toscafund, THCP Advisory and Ares Management, so neither the asserted acquirer nor an unequivocally completed agreement is established by the cited official record (Source 1, The Standard; Source 3, LSE).
The Opponent relies on outdated Takeover Panel and pre-deal material (Sources 2 and 12) that predate the firm agreement, while multiple same-day verified reports establish that Spire's board did agree the 250p cash offer valuing the equity at about £1.03 billion (Sources 1 standard.co.uk, 3 lse.co.uk, 5 independent.co.uk, 7 cityam.com). The Opponent's quibble over bidder naming is a false dichotomy: those same sources identify Tulip UK Bidco as the vehicle owned by funds managed or advised by Toscafund with THCP/Three Hills and Ares, which is precisely the Toscafund-led consortium the claim describes.
Panel Review
3 reviewers assessed the evidence and the arguments.
Reviewer 1 — The Logic Examiner
Multiple same-day verified reports (Sources 1, 3, 4, 5, 7) directly state that Spire's board agreed a 250p-per-share cash offer from Tulip UK Bidco, a vehicle owned by funds managed/advised by Toscafund with THCP/Three Hills and Ares, valuing the equity at about £1.03 billion, forming a complete and consistent logical chain from primary deal terms to the claim. Older Takeover Panel and pre-firm-offer material (Sources 2, 12) is superseded by the September 2026 agreement announcements, so the claim follows without material gaps or fallacies.
Reviewer 2 — The Source Auditor
Multiple independent, high-quality outlets published on 2026-09-05 through 2026-09-07 — including standard.co.uk, lse.co.uk, theguardian.com, independent.co.uk, cityam.com, and uk.advfn.com — consistently and specifically confirm that Spire Healthcare's board agreed to a 250p-per-share cash offer valuing the company at approximately £1.03 billion, from Tulip UK Bidco, a vehicle owned by funds managed/advised by Toscafund Asset Management (alongside THCP/Three Hills and Ares). The Opponent's reliance on the Takeover Panel disclosure table and a pre-deal Kalkine article is outdated relative to these same-day confirmed reports, and the 'led by Toscafund' framing is a reasonable characterization since Toscafund is consistently named first/primary among the consortium funds; the underlying facts (250p/share, ~£1.03bn valuation, agreed deal) are well-corroborated by reliable, largely independent sources.
Reviewer 3 — The Precision Analyst
The claim's quantities and scope are fully supported by the evidence, which confirms Spire Healthcare agreed to a 250p-per-share takeover by a Toscafund-led consortium (Sources 1, 3, 4, 7). Multiple recent sources also verify this deal values the company's share capital at approximately £1.03 billion (Sources 1, 3, 5, 7, 13).
Panel summary
Source analysis shows broad, current corroboration from major news organizations and Spire's official deal materials. The logic is direct: Spire's board agreed to the cash offer, the bidder is a consortium vehicle involving Toscafund, Three Hills and Ares, and the stated equity valuation follows from the 250p-per-share terms. Quantitative analysis confirms both the offer price and approximately £1.03 billion valuation. Older procedural disclosures and pre-offer reporting were superseded by the September 2026 announcement. Describing the consortium as Toscafund-led is consistent with current reporting and does not materially distort the ownership structure.